Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-16

Clinical Trial Update: 0.2% Chlorhexidine vs MicroRepair ABX in Gingivitis [NA]

View source ↗

Summary

A clinical trial comparing 0.2% chlorhexidine mouthwash to MicroRepair ABX for gingivitis and dental plaque is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (0.2%) (chlorhexidine digluconate)
  • MicroRepair ABX

Snippet

Sponsor: University of Pavia | Conditions: Gingivitis and Periodontal Diseases, Dental Plaque | NA | Status: RECRUITING